Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

28.81
+1.304.73%
Post-market: 28.860.0500+0.17%19:59 EDT
Volume:11.98M
Turnover:345.20M
Market Cap:6.72B
PE:-46.24
High:29.44
Open:27.38
Low:27.14
Close:27.51
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:213.68M
Volume Ratio:1.54
T/O Rate:5.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:20.74
PE(LYR):56.24

Loading ...

Hims & Hers Health is Maintained at Neutral by B of a Securities

Dow Jones
·
Jul 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Jul 09

Movement Alert|Hims & Hers Health Falls 5.11% in Regular Trading, Trading at $34.26

Market Focus
·
Jul 08

Movement Alert|Hims & Hers Health Falls 5.2% in Pre-Market Trading, Trading at $34.45

Market Focus
·
Jul 08

Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56

Reuters
·
Jul 08

Movement Alert|Hims & Hers Health Declines 5.02% in Regular Trading, Trading at $36.33

Market Focus
·
Jul 08

Movement Alert|Hims & Hers Health Rises 5.14% in Regular Trading, Continued Momentum Following BofA Price Target Upgrade

Market Focus
·
Jul 06

Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

Dow Jones
·
Jul 05

Hims & Hers Health (HIMS) Secures $400 Million Financing, Is The Upside Already Priced In?

Simply Wall St.
·
Jul 02

Hims & Hers Health - Receivables Purchase Agreement Has Initial 364-day Term, Extendable by Written Agreement - SEC Filing

THOMSON REUTERS
·
Jul 02

Hims & Hers Signs USD 400 Million Receivables Purchase Facility with Jpmorgan Chase

Reuters
·
Jul 02

Sector Update: Healthcare

MT Newswires Live
·
Jul 02

Movement Alert|Hims & Hers Health Rises 5.12% in Regular Trading, BofA Securities Raises Price Target to $36 From $25

Market Focus
·
Jul 01

BofA Securities Adjusts Hims & Hers Health Price Target to $36 From $25, Maintains Neutral Rating

MT Newswires Live
·
Jul 01

Hims & Hers Health is Maintained at Neutral by B of a Securities

Dow Jones
·
Jul 01

HIMS Stock Jumps after Canaccord Raises Price Target to Street-High of $40

TIPRANKS
·
Jul 01

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)

TIPRANKS
·
Jul 01

Hims & Hers : Bofa Global Research Raises Price Objective to $36.00 from $25.00

THOMSON REUTERS
·
Jul 01

Moderately bullish activity in Hims and Hers Health with shares up 5.3%

TIPRANKS
·
Jun 26

Movement Alert|Hims & Hers Health Rises 5.54% in Regular Trading, Barclays Raises Target Price to $39 Amid Oversold Rebound

Market Focus
·
Jun 26